Overview

Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer

Status:
Completed
Trial end date:
2003-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which combination chemotherapy regimen is most effective in treating advanced stomach cancer. PURPOSE: Randomized phase II trial to compare the effectiveness of different regimens of combination chemotherapy in treating patients who have advanced stomach cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Swiss Group for Clinical Cancer Research
Treatments:
Cisplatin
Docetaxel
Epirubicin
Fluorouracil